Table 3.
Univariate analysis. Comparing first-line management of PPH in women with severe PPH stratified by mode of birth between France and the Netherlands (2011–2013).
| Vaginal Birth |
Cesarean birth |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| France N = 214 |
The Netherlands N = 1002 |
P-value | France N = 270 |
The Netherlands N = 342 |
P-value | |||||
| Manual removal placenta | 65 | (30.4) | 328 | (32.8) | 0.50 | 232 | (85.9) | 301 | (88.0) | 0.44 |
| Uterine exploration after spontaneous birth placenta | 149 | (69.6) | 658 | (65.8) | 0.26 | 30 | (11.1) | 36 | (10.5) | 0.81 |
| Urinary catheterization | 193 | (90.1) | 932 | (93.0) | 0.15 | 270 | (1 0 0) | 342 | (1 0 0) | 1 |
| Oxytocin infusion1 | 151 | (71.9) | 677 | (67.5) | 0.39 | 192 | (71.1) | 231 | (67.5) | 0.34 |
| Time PPH diagnosis – oxytocin infusion (median (IQR)) (minutes) | 5 | (0–15) | 7 (0–18) | 0.42 | 0 (0–5) | 1 (0–7) | 0.64 | |||
1In France, Oxytocin 5–10 IU slow IV followed by oxytocin infusion of 5–10 IU/h for 2 h (Max: 40 IU). In the Netherlands: Oxytocin 5 IU slow IV, followed by oxytocin infusion 2.5 IE/4h. PPH = postpartum hemorrhage. IQR = interquartile range